Rapid diagnostic testing for antimicrobial stewardship: Utility in Asia Pacific
Document Type
Article
Publication Date
1-1-2021
Abstract
Rapid diagnostic testing (RDT) can provide prompt, accurate identification of infectious organisms and be a key component of antimicrobial stewardship (AMS) programs. However, their use is less widespread in Asia Pacific than western countries. Cost can be prohibitive, particularly in less resource-replete settings. A selective approach is required, possibly focusing on the initiation of antimicrobials, for differentiating bacterial versus viral infections and identifying locally relevant tropical diseases. Across Asia Pacific, more data are needed on RDT use within AMS, focusing on the impact on antimicrobial usage, patient morbidity and mortality, and cost effectiveness. Moreover, in the absence of formal guidelines, regional consensus statements to guide clinical practice are warranted. These will provide a regionally relevant definition for RDT; greater consensus on its role in managing infections; advice on implementation and overcoming barriers; and guidance on optimizing human resource capacity. By addressing these issues, the outcomes of AMS programs should improve. © 2021 Cambridge University Press. All rights reserved.
Keywords
antimicrobial
Divisions
medicinedept
Funders
National Institutes of Health, Japan Agency for Medical Research and Development - bioMerieux
Publication Title
Infection Control and Hospital Epidemiology
Volume
42
Issue
7
Publisher
Cambridge Univ Press